Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs propofol maintenance anesthesia in HOCM patients undergoing PIMSRA
ChiCTR2600134559Phase 4Not yet recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- Aug 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, propofol and remifentanil in Hypertrophic Obstructive Cardiomyopathy (HOCM) (2 arms), sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoint: Incidence of clinically significant intraoperative hypotension requiring rescue treatment. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofolremifentanil
03
Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Beyond the preview
Go deeper on ChiCTR2600134559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134559.